Thermo Fisher Scientific Inc.(TMO)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
TMO | 228.66 B | 33.25x | 10.50% | 15.04% | $18.60 | 13.52% | 0.81 | 30.00% | $647.00 | $434.83 |
DHR | 148.35 B | 37.55x | 5.50% | 15.95% | $5.62 | 7.61% | 0.53 | 74.00% | $241.78 | $160.60 |
IQV | 44.71 B | 33.78x | 8.70% | 8.10% | $8.04 | 22.82% | 2.58 | - | $265.25 | $154.50 |
A | 42.29 B | 29.58x | 8.10% | 19.53% | $5.07 | 20.97% | 0.54 | 66.00% | $163.75 | $108.14 |
WAT | 40.61 B | 104.96x | 1.13% | 3.59% | $3.94 | 1.92% | 0.36 | - | $426.22 | $282.77 |
Peer Valuation & Performance Analysis
Peer group analysis for Thermo Fisher Scientific Inc. (TMO) compared to its primary competitors (including DHR, IQV, A) reveals distinct metrics. TMO trades at a valuation discount relative to its competitors, with a P/E ratio of 33.2x versus the peer average of 51.5x (representing a 35% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, TMO's revenue growth of 10.5% exceeds the peer average of 5.9%, highlighting its competitive strength and market share gains. Additionally, it boasts superior profitability with a net margin of 15.0% compared to the peer average of 11.8%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• TMO ranks #2 in P/E ratio, #1 in revenue growth, and #3 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $614.03 | $622.91 | $603.52 | $618.43 | 1,804,900 | +0.72% |
| 2026-09-02 | $601.63 | $614.60 | $600.70 | $608.54 | 1,617,000 | +1.15% |
| 2026-09-01 | $619.00 | $621.00 | $599.52 | $600.50 | 1,385,000 | -2.99% |
| 2026-08-31 | $614.38 | $620.72 | $610.35 | $617.10 | 1,429,100 | +0.44% |
| 2026-08-28 | $626.58 | $630.00 | $617.45 | $622.18 | 1,016,600 | -0.70% |
| 2026-08-27 | $629.47 | $637.13 | $626.33 | $630.70 | 1,466,900 | +0.20% |
| 2026-08-26 | $622.23 | $636.06 | $622.23 | $633.71 | 1,843,000 | +1.84% |
| 2026-08-25 | $631.01 | $647.00 | $618.03 | $628.15 | 1,535,300 | -0.45% |
| 2026-08-24 | $630.00 | $630.00 | $615.97 | $628.74 | 1,727,100 | -0.20% |
| 2026-08-21 | $626.48 | $629.51 | $616.27 | $629.27 | 1,556,000 | +0.45% |
| 2026-08-20 | $609.85 | $634.70 | $607.37 | $627.55 | 2,750,100 | +2.90% |
| 2026-08-19 | $595.11 | $620.48 | $595.00 | $613.54 | 2,507,200 | +3.10% |
| 2026-08-18 | $588.87 | $592.22 | $584.86 | $589.04 | 1,721,600 | +0.03% |
| 2026-08-17 | $582.55 | $592.32 | $580.00 | $585.51 | 887,300 | +0.51% |
| 2026-08-14 | $592.11 | $594.74 | $587.51 | $588.29 | 1,057,600 | -0.65% |
Explore More Analysis for TMO
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.